GCTS GCT Semiconductor Holding, Inc.
Semiconductors & Related Devices · NYSE · SEC CIK 1851961 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY21.2%
TTM net income YoY-18.6%
TTM EPS YoY20.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin-12.6%
Operating margin-696.8%
Net margin-988.7%
FCF margin-914.6%
EBITDA margin-671.9%
Returns
ROE—
ROA-148.6%
ROIC (approx.)—
Asset turnover0.15x
Leverage & solvency
Liabilities / assets252.3%
Debt / equity—
Current ratio0.52x
Interest coverage-5.92x
Cash quality & payout
Operating cash flow / net income0.85x
Accruals ratio-22.0%
Payout ratio—
Capex / revenue72.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $2.87M | $9.13M |
| Cost of revenue | $4.68M | $4.05M |
| Gross profit | -$1.82M | $5.08M |
| R&D expense | $14.01M | $17.33M |
| SG&A expense | $16.48M | $10.80M |
| Operating income | -$36.54M | -$13.12M |
| Interest expense | $6.03M | $3.87M |
| Pretax income | -$42.47M | -$11.93M |
| Income tax | $902,000 | $445,000 |
| Net income | -$43.37M | -$12.38M |
| EBITDA | -$35.80M | -$12.43M |
| EPS (basic) | -0.82 | -0.30 |
| EPS (diluted) | -0.82 | -0.30 |
| Weighted avg. shares (diluted) | 52.87M | 40.63M |
| Balance sheet | ||
| Cash & equivalents | $590,000 | $1.44M |
| Receivables | $2.60M | $5.74M |
| Inventory | $947,000 | $2.98M |
| Current assets | $11.88M | $17.59M |
| PP&E, net | $2.67M | $869,000 |
| Intangibles | $0 | $65,000 |
| Total assets | $15.64M | $19.90M |
| Current liabilities | $79.59M | $60.92M |
| Short-term debt | $56.59M | $37.63M |
| Long-term debt | $6.05M | $4.95M |
| Total debt | $62.63M | $42.57M |
| Total liabilities | $98.94M | $79.21M |
| Shareholders' equity | -$83.29M | -$59.31M |
| Net debt | $62.05M | $41.14M |
| Shares outstanding | 58.14M | 47.99M |
| Cash flow statement | ||
| Operating cash flow | -$30.68M | -$30.96M |
| Capital expenditure | $2.41M | $542,000 |
| Free cash flow | -$33.09M | -$31.50M |
| Investing cash flow | -$2.41M | -$542,000 |
| Financing cash flow | $32.25M | $36.47M |
| Depreciation & amortization | $744,000 | $691,000 |
| Stock-based compensation | $6.33M | $2.70M |
Free plan shows the latest 2 periods; Pro shows all 4 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.